Non-Antibody Products — page 287 of 368
Non-Antibody Products
Page 287 of 368
| Name | Description | Size | Catalog # | Supplier | |
|---|---|---|---|---|---|
| Rolapitant | selective for NK1 over NK2 and NK3 and lacks activity in a panel of 1… | 10 mg | 23906-10 |
 CAYMAN CHEMICAL COMPANY |
More Info |
| Rolapitant | selective for NK1 over NK2 and NK3 and lacks activity in a panel of 1… | 5 mg | 23906-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 20(R)-Protopanaxadiol | 50 = 6.1 µM); inhibits the growth of A549, SKOV3, SK-Mel-2, P388, L1… | 10 mg | 25052-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 20(R)-Protopanaxadiol | 50 = 6.1 µM); inhibits the growth of A549, SKOV3, SK-Mel-2, P388, L1… | 25 mg | 25052-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 20(R)-Protopanaxadiol | 50 = 6.1 µM); inhibits the growth of A549, SKOV3, SK-Mel-2, P388, L1… | 5 mg | 25052-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 20(R)-Protopanaxadiol | 50 = 6.1 µM); inhibits the growth of A549, SKOV3, SK-Mel-2, P388, L1… | 50 mg | 25052-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| S-Geranylgeranyl-L-glutathione | A P2RY8 ligand; selectively induces internalization of P2RY8 over S
| 1 mg |
9004116-1 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| S-Geranylgeranyl-L-glutathione | A P2RY8 ligand; selectively induces internalization of P2RY8 over S
| 10 mg |
9004116-10 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| S-Geranylgeranyl-L-glutathione | A P2RY8 ligand; selectively induces internalization of P2RY8 over S
| 5 mg |
9004116-5 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| 17(S)-HDHA | A hydroxy fatty acid formed from DHA by 15-LO and is a precursor to 17(| 100 µg |
10009799-100 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| 17(S)-HDHA | A hydroxy fatty acid formed from DHA by 15-LO and is a precursor to 17(| 25 µg |
10009799-25 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| 17(S)-HDHA | A hydroxy fatty acid formed from DHA by 15-LO and is a precursor to 17(| 250 µg |
10009799-250 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| 17(S)-HDHA | A hydroxy fatty acid formed from DHA by 15-LO and is a precursor to 17(| 50 µg |
10009799-50 |
|
CAYMAN CHEMICAL COMPANY
More Info
|
|
| SKLB1002 | s = 619->10,000 nM); inhibits tube formation, migration, and VEGF… | 10 mg | 34422-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| SKLB1002 | s = 619->10,000 nM); inhibits tube formation, migration, and VEGF… | 25 mg | 34422-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| SKLB1002 | s = 619->10,000 nM); inhibits tube formation, migration, and VEGF… | 5 mg | 34422-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Tianeptine Metabolite MC5 (sodium salt) | HEK293T cells expressing human MOR over human DOR (EC50s = 0.454… | 1 mg | 36694-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Tianeptine Metabolite MC5 (sodium salt) | HEK293T cells expressing human MOR over human DOR (EC50s = 0.454… | 10 mg | 36694-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Tianeptine Metabolite MC5 (sodium salt) | HEK293T cells expressing human MOR over human DOR (EC50s = 0.454… | 5 mg | 36694-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lapatinib | A dual inhibitor of EGFR and ErbB2 (IC50s = 19 and 3 nM, respecti… | 10 mg | 11493-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lapatinib | A dual inhibitor of EGFR and ErbB2 (IC50s = 19 and 3 nM, respecti… | 100 mg | 11493-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lapatinib | A dual inhibitor of EGFR and ErbB2 (IC50s = 19 and 3 nM, respecti… | 25 mg | 11493-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lapatinib | A dual inhibitor of EGFR and ErbB2 (IC50s = 19 and 3 nM, respecti… | 5 mg | 11493-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| NG 25 (hydrochloride hydrate) | An inhibitor of MAP4K2 and TAK1 (IC50s = 21.7 and 149 nM, respect… | 1 mg | 27579-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| NG 25 (hydrochloride hydrate) | An inhibitor of MAP4K2 and TAK1 (IC50s = 21.7 and 149 nM, respect… | 10 mg | 27579-10 |
CAYMAN CHEMICAL COMPANY |
More Info |